Mauna Kea endomicroscopy system wins FDA nod
Mauna Kea Technologies has received the US Food and Drug Administration (FDA) approval for its next-generation endomicroscopy system - Cellvizio 100 Series to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts.
Cellvizio, a probe-based Confocal Laser Endomicroscopy (pCLE) system, is used in gastroenterology applications to aid physicians with real-time microscopic images of tissue inside the body.
The Cellvizio 100 Series integrates enhanced image quality and a 'Cine Review' feature that aids physicians to focus on a single frame of clinical evidence for as long as necessary.
The images facilitate the diagnosis and surveillance of patients, improving the detection of pre-cancerous lesions and helps physicians to make immediate treatment decisions for their patients.
Other features include an improved user interface, faster start up and shut down times, and data exchange allowing images to be exported to patient's medical files with ease, claims Mauna Kea.
Latest News
Related News
Diagnostics> Endoscopy Devices
Related Dates
2011> August
Related Industries
Pharmaceuticals and Healthcare> Medical Devices> Endoscopy Devices> Endoscopy Visualization Systems
Related Insight
Suppliers Directory
Diagnostics In Vitro Diagnostics Diagnostic Imaging Endoscopy Devices
Patient Care Patient Monitoring Surgical & Supplies Wound Care Management
Technology Automation Healthcare IT Packaging
Contract Services
Certification
Endoscopy Devices Intelligence
GlobalData’s new report, “External Defibrillators - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2016” provides key data, information and analysis on the global external defibrillators market. The report provides market landscape, competitive landscape and market trends information the external defibrillators market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Buy online from $3500

Comments may be moderated for spam, obscenities or defamation.